161 related articles for article (PubMed ID: 30600180)
1. Combination of 3-methyladenine therapy and Asn-Gly-Arg (NGR)-modified mesoporous silica nanoparticles loaded with temozolomide for glioma therapy in vitro.
Zhang P; Tang M; Huang Q; Zhao G; Huang N; Zhang X; Tan Y; Cheng Y
Biochem Biophys Res Commun; 2019 Feb; 509(2):549-556. PubMed ID: 30600180
[TBL] [Abstract][Full Text] [Related]
2. Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.
Hu J; Zhang X; Wen Z; Tan Y; Huang N; Cheng S; Zheng H; Cheng Y
Oncotarget; 2016 Nov; 7(45):73681-73696. PubMed ID: 27655664
[TBL] [Abstract][Full Text] [Related]
3. Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells.
Bertucci A; Prasetyanto EA; Septiadi D; Manicardi A; Brognara E; Gambari R; Corradini R; De Cola L
Small; 2015 Nov; 11(42):5687-95. PubMed ID: 26395266
[TBL] [Abstract][Full Text] [Related]
4. Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect.
Xu M; Li G; Zhang H; Chen X; Li Y; Yao Q; Xie M
Drug Deliv; 2020 Dec; 27(1):983-995. PubMed ID: 32611218
[TBL] [Abstract][Full Text] [Related]
5. Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma.
Shi H; Sun S; Xu H; Zhao Z; Han Z; Jia J; Wu D; Lu J; Liu H; Yu R
Int J Nanomedicine; 2020; 15():3347-3362. PubMed ID: 32494134
[TBL] [Abstract][Full Text] [Related]
6. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
7. Temozolomide and chloroquine co-loaded mesoporous silica nanoparticles are effective against glioma.
Zhang P; Cao F; Zhang J; Tan Y; Yao S
Heliyon; 2023 Aug; 9(8):e18490. PubMed ID: 37576252
[TBL] [Abstract][Full Text] [Related]
8. Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma.
Shao N; Mao J; Xue L; Wang R; Zhi F; Lan Q
J Neurooncol; 2019 Jan; 141(2):277-288. PubMed ID: 30460630
[TBL] [Abstract][Full Text] [Related]
9. Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and
Shao L; Li Y; Huang F; Wang X; Lu J; Jia F; Pan Z; Cui X; Ge G; Deng X; Wu Y
Theranostics; 2020; 10(16):7273-7286. PubMed ID: 32641992
[TBL] [Abstract][Full Text] [Related]
10. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
[TBL] [Abstract][Full Text] [Related]
11. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
Zhao BJ; Ke XY; Huang Y; Chen XM; Zhao X; Zhao BX; Lu WL; Lou JN; Zhang X; Zhang Q
J Drug Target; 2011 Jun; 19(5):382-90. PubMed ID: 20677914
[TBL] [Abstract][Full Text] [Related]
12. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
13. Breakable mesoporous silica nanoparticles for targeted drug delivery.
Maggini L; Cabrera I; Ruiz-Carretero A; Prasetyanto EA; Robinet E; De Cola L
Nanoscale; 2016 Apr; 8(13):7240-7. PubMed ID: 26974603
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells.
Zhang X; Ni Q; Wang Y; Fan H; Li Y
Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900
[TBL] [Abstract][Full Text] [Related]
15. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X
Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899
[TBL] [Abstract][Full Text] [Related]
16. Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma.
Emamgholizadeh Minaei S; Khoei S; Khoee S; Karimi MR
Int J Biochem Cell Biol; 2019 Mar; 108():72-83. PubMed ID: 30660689
[TBL] [Abstract][Full Text] [Related]
17. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
18. Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ/PSi nanoparticles via decreasing the stemness in glioma.
Zeng X; Wang Q; Tan X; Jia L; Li Y; Hu M; Zhang Z; Bai X; Zhu Y; Yang X
J Nanobiotechnology; 2019 Apr; 17(1):47. PubMed ID: 30935403
[TBL] [Abstract][Full Text] [Related]
19. Anticancer Effect of α-Tocopheryl Succinate Delivered by Mitochondria-Targeted Mesoporous Silica Nanoparticles.
Qu Q; Ma X; Zhao Y
ACS Appl Mater Interfaces; 2016 Dec; 8(50):34261-34269. PubMed ID: 27998109
[TBL] [Abstract][Full Text] [Related]
20. Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).
Kumari S; Ahsan SM; Kumar JM; Kondapi AK; Rao NM
Sci Rep; 2017 Jul; 7(1):6602. PubMed ID: 28747713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
